Dr Imran Ahmad - Models of Advanced Prostate Cancer

Senior Clinical Lecturer in Urology, University of Glasgow

Cancer Research UK Clinician Scientist

Introduction

Ahmad head 003

Prostate cancer is a leading cause of cancer mortality in men in the western world. Identifying and understanding the pathways that drive advanced and treatment-resistant prostate cancer will provide important information that will allow prognostication and individualised patient treatments.

Androgens have been found to be important for prostate cancer progression and androgen deprivation therapy is usually effective at initially controlling the disease. In many cases, however, there is a recurrent castration-resistant phase, for which there is no effective treatment.

My current research interest is in understanding the mechanisms of treatment-resistance in advanced prostate cancer. Work in my laboratory uses state-of-the-art in vivo models in conjunction with patient samples to interrogate the disease processes in advanced and treatment-resistant prostate cancer. This work will help to provide information on drivers of prostate cancer progression and to identify novel biomarkers of disease and/or drug targets to treat the disease.

As an Honorary Consultant Urological and Robotic Surgeon based at the Queen Elizabeth University Hospital in Glasgow, I currently perform robotic surgery for localised/locally advanced prostate cancer.


Starter Grant for Clinical Lecturers awardee

Dr Imran Ahmad explains how a Starter Grant from the Academy of Medical Sciences allowed him to continue his research following his PhD. Click here to read the interview.